Prostate Cancer Patient Receives First Treatment Using Latest Version Of Vitesse Real-Time Brachytherapy Planning System From Varian Medical Systems
A prostate cancer patient has become the first person in the world to be treated using the latest version of Varian's Vitesse™ real time planning solution for planning and performing advanced high-dose-rate (HDR), ultrasound-guided brachytherapy treatments. The treatment took place at the Levine Cancer Institute in Charlotte, North Carolina. "Our team was very impressed overall with this treatment planning system," says Dr. Michael Haake, chief, division of Radiation Oncology at Carolinas Medical Center, Levine Cancer Institute... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 19, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Combination RT offers hope to late-stage esophageal cancer patients
Just over half of patients with advanced-stage esophageal cancer who are unsuitable for standard curative treatment survive for a year after receiving a combination of external beam radiotherapy and high-dose rate brachytherapy, report researchers. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - February 7, 2013 Category: Cancer & Oncology Source Type: news

Older Women with Breast Cancer Experience More Complications with Brachytherapy Than Whole Breast Irradiation
Source: Agency for Healthcare Research and Quality Related MedlinePlus Page: Breast Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 5, 2013 Category: Consumer Health News Source Type: news

Delayed hematuria common after prostate brachytherapy
A significant proportion of patients with prostate cancer who are treated with brachytherapy develop gross hematuria years later, report researchers. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - February 5, 2013 Category: Cancer & Oncology Source Type: news

Delayed hematuria common after prostate brachytherapy
A significant proportion of patients with prostate cancer who are treated with brachytherapy develop gross hematuria years later, report researchers. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - February 5, 2013 Category: Cancer & Oncology Source Type: news

Invitation to the 2nd ESTRO Forum
(European Society for Radiotherapy and Oncology (ESTRO)) The 2nd ESTRO Forum will feature new research results in clinical radiation oncology, radiobiology, physics, technology, and brachytherapy, presented by top doctors and scientists from all over the world working together for the benefit of cancer patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 4, 2013 Category: Global & Universal Source Type: news

Delayed hematuria common after prostate brachytherapy
A significant proportion of patients with prostate cancer who are treated with brachytherapy develop gross hematuria years later, report researchers. (Source: MedWire News - Urology)
Source: MedWire News - Urology - February 4, 2013 Category: Urology & Nephrology Source Type: news

Delayed hematuria common after prostate brachytherapy
A significant proportion of patients with prostate cancer who are treated with brachytherapy develop gross hematuria years later, report researchers. (Source: MedWire News - Prostate Cancer)
Source: MedWire News - Prostate Cancer - February 4, 2013 Category: Cancer & Oncology Source Type: news

Vitesse™ Brachytherapy Treatment Planning Software Receives FDA 510(k) Clearance
Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse™ real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.Â� "This version of Vitesse reduces the number and complexity of steps involved in planning and completing a treatment... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 29, 2013 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse(TM) Brachytherapy Treatment Planning Software
Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance PALO ALTO, Calif., Jan. 24, 2013 (HSMN NewsFeed) -- Varian Medical Systems (VAR) has received an FDA 510(... Devices, Oncology, FDAVarian Medical Systems, Vitesse, brachytherapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2013 Category: Pharmaceuticals Source Type: news

New specialised commissioning draft service specifications and a clinical policy added to consultation
Source: NHS Commissioning Board Area: News The NHS Commissioning Board (NHS CB) has added seven new draft service specifications and a further clinical policy for specialised commissioning to its consultation. The consultation period for these new additions will run from 11 January to 22 February 2013.   The newly published draft clinical policy is: Complex Endovascular Stent Grafts in Abdominal Aortic Aneurysm.   The proposed service specifications are:   . Complex Home Ventilation . Severe Asthma . Colorectal: Complex Inflammatory Bowel Disease . Brachytherapy .&nbs...
Source: NeLM - News - January 11, 2013 Category: Drugs & Pharmacology Source Type: news